This video highlights a clinical-genomic risk classification system that is highly prognostic for distant metastasis and more accurate than clinical risk assessments.
Daniel Eidelberg Spratt, MD
Advertisement
Articles by Daniel Eidelberg Spratt, MD
Advertisement
Latest Updated Articles
Novel Prostate Cancer Risk Classifier Highly Prognostic for MetastasesPublished: June 8th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Response Rates Show Promise in Phase 1 Trial Involving ASCT in Metastatic PDAC
2
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
3
Case 2: Patient With High-Risk RRMM Relapsing After BCMA CAR T-Cell Therapy
4
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
5
